Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
BCL2 expression
i
Other names:
BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Associations
(9)
News
Trials
C2 | Sensitive
C3 | Sensitive
D | Sensitive
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
BCL Inhibitors
CD Protein Inhibitors
Immunotherapy
Interleukins
Cancel
Diffuse Large B Cell Lymphoma
Acute Myelogenous Leukemia
Non-Hodgkin’s Lymphoma
Multiple Myeloma
Hodgkin Lymphoma
venetoclax
C2
BCL2 expression
|
Acute Myelogenous Leukemia
|
venetoclax
C2
BCL2 expression
|
Non-Hodgkin’s Lymphoma
|
venetoclax
D
BCL2 expression
|
Hodgkin Lymphoma
|
venetoclax
lenalidomide
C2
BCL2 expression
|
Diffuse Large B Cell Lymphoma
|
lenalidomide
venetoclax + obinutuzumab
C2
BCL2 expression
|
Diffuse Large B Cell Lymphoma
|
venetoclax + obinutuzumab
S63845
D
BCL2 expression
|
Diffuse Large B Cell Lymphoma
|
S63845
D
BCL2 expression
|
Multiple Myeloma
|
S63845
ABVD
C3
BCL2 expression
|
Hodgkin Lymphoma
|
ABVD
venetoclax + S63845
D
BCL2 expression
|
Diffuse Large B Cell Lymphoma
|
venetoclax + S63845
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
